Cadence Taps Latham For $100M Offering
Cadence Pharmaceuticals Inc. has registered for an aggregate initial offering of up to $100 million in securities with the U.S. Securities and Exchange Commission....To view the full article, register now.
Already a subscriber? Click here to view full article